⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 18, 2024Open Access

Figure S6 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Priyanka S. Rana James J. Ignatz-Hoover Byung‐Gyu Kim Ehsan Malek Yuriy Federov Drew Adams Timothy A. Chan James J. Driscoll

View Full Paper

Ask AI

Bookmark

Share

Abstract

Fig. S6. Dose-dependent effect of ACY-1215 and tubastatin-A on the biochemical activity of the HDACs and SIRTs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rana et al. (2024) studied this question.

synapsesocial.com/papers/68e64524b6db6435875d627a https://doi.org/10.1158/2767-9764.26058188.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S18 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
2Figure S3 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
3FIGURE 3 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
4Figure S1 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
5Table S6 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024

More related papers

Table S6 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
Table S5 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
Table S5 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024